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Abstract
Objective—Mitochondrial dysfunction in peripheral blood mononuclear cells (PBMCs) has been
linked to immune dysregulation and organ failure in adult sepsis but pediatric data are limited. We
hypothesized that pediatric septic shock patients exhibit mitochondrial dysfunction within PBMCs
which in turn correlates with global organ injury.
Design—Prospective observational study.
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Setting—Academic pediatric intensive care unit (PICU).
Patients—Thirteen pediatric patients with septic shock and ≥2 organ failures and 11 PICU
controls without sepsis or organ failure.
Interventions—Ex vivo measurements of mitochondrial oxygen consumption and membrane
potential (ΔΨm) were performed in intact PBMCs on day 1–2 and day 5–7 of septic illness and in
controls. The Pediatric Logistic Organ Dysfunction (PELOD) score, inotrope score, and organ
failure-free days were determined from medical records.
Measurements and Main Results—Spare respiratory capacity (SRC), an index of
bioenergetic reserve, was lower in septic PBMCs on day 1–2 (median 1.81, IQR 0.52–2.09 pmol
O2/s/106 cells) compared to controls (5.55, 2.80–7.21; p=0.03). SRC normalized by day 5–7.
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Septic patients on day 1–2 exhibited a higher ratio of LEAK to maximal respiration than controls
(17% versus <1%, p=0.047) with normalization by day 5–7 (1%, p=0.008), suggesting
mitochondrial uncoupling early in sepsis. However, septic PBMCs exhibited no differences in
basal or ATP-linked oxygen consumption or ΔΨm. Oxygen consumption did not correlate with
PELOD, inotrope score, or organ failure-free days (all p>0.05). While there was a weak overall
association between ΔΨm on day 1–2 and organ failure-free days (Spearman’s ρ=0.56, p=0.06),
septic patients with normal organ function by day 7 exhibited higher ΔΨm on day 1–2 compared
to patients with organ failure for >7 days (p=0.04).
Conclusions—Mitochondrial dysfunction was present in PBMCs in pediatric sepsis, evidenced
by decreased bioenergetic reserve and increased uncoupling. Mitochondrial membrane potential,
but not respiration, was associated with duration of organ injury.
Keywords
mitochondria; bioenergetic reserve; energy failure; sepsis; critically ill children
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The sepsis syndrome is a leading cause of morbidity and mortality in pediatric patients (1).
Despite antibiotics and early goal-directed therapy, 20–40% of children with sepsis develop
organ injury requiring hospitalization in an intensive care unit (2). For critically ill children
with sepsis-induced organ injury, therapy remains limited to supportive care and mortality is
between 15–50% (2–4). In the current era, most of these deaths are related to multiple organ
dysfunction syndrome (MODS) (2) or secondary infection (5).
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Mitochondrial dysfunction has been implicated in the pathogenesis of organ injury and
immune suppresion in adult sepsis but direct mitochondrial measurements in pediatric sepsis
are limited (6). Under normal conditions, oxygen consumption through the mitochondrial
electron transport system (ETS) is used to drive ATP production. Failure of mitochondria to
efficiently use oxygen to sustain ATP production results in an energy deficit that can impair
cell, and ultimately, organ function (7). Mitochondrial dysfunction can be detected by
measuring oxygen consumption and mitochondrial membrane potential (ΔΨm). Oxygen
consumption reflects mitochondrial oxidative respiration and measures using inhibitors and
uncouplers are well standardized (8, 9). The spare respiratory capacity (SRC), in particular,
reflects the ability of the ETS to keep pace with an increase in energy demand (8, 10, 11).
ΔΨm is the difference in electrical potential across the inner mitochondrial membrane and
reflects the ability of the ETS to maintain the proton gradient that drives ATP production.
Mitochondrial abnormalities are evident in heart, kidney, and liver following septic insults
in animal models (12–14). However, direct evidence for mitochondrial dysfunction in
human studies is limited, largely due to the impracticality of tissue biopsies in critically ill
patients (15, 16). Several studies have shown that alterations in mitochondrial respiration in
peripheral blood mononuclear cells (PBMCs)—monocytes and lymphocytes--are associated
with disease severity, immune suppression, and mortality (17–21). Under quiescent
conditions, PBMCs rely more on mitochondrial respiration than glycolysis to meet
metabolic demands and exhibit a substantial SRC (22–24). These data suggest promise for
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using PBMCs to gauge systemic mitochondrial derangements in vital organs and to impart
insight into a possible mechanism of sepsis-induced immunosuppression (25–27). At
present, there are no data on mitochondrial dysfunction in PBMCs from children with
sepsis-induced MODS. Maturational differences in the response to sepsis (28) and agerelated changes in mitochondrial biology preclude direct extrapolation of adult data to
younger patients (29).
We sought to determine if measurable defects in mitochondrial dysfunction occur within
PBMCs and correlate with severity and duration of organ injury in pediatric septic shock.
We hypothesized that mitochondrial oxygen consumption and ΔΨm are decreased in
PBMCs from septic pediatric patients and correlate with severity and duration of organ
injury.

METHODS
This prospective, observational study was performed in the pediatric intensive care unit
(PICU) at The Children’s Hospital of Philadelphia from July 2012 to September 2013. The
study was approved by the Institutional Review Board and informed consent was obtained.
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Study Population
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All patients ≤ 18 years-old admitted to the PICU who met criteria for septic shock and
MODS as defined by the International Pediatric Sepsis Consensus Conference (30) were
screened for eligibility. Consensus criteria define septic shock as 1) ≥ 2 age-based systemic
inflammatory response syndrome criteria, 2) confirmed or suspected invasive infection, and
3) cardiovascular dysfunction (hypotension, need for vasoactive agent, or impaired
perfusion despite 40 mL/kg intravenous fluid). MODS, defined as at least two concurrent
dysfunctional organ systems (30), was required to be present for at least 12 hours. To reduce
the likelihood that organ dysfunction was solely a consequence of inadequate resuscitation,
only patients who achieved an age-appropriate minimum systolic blood pressure within 24
hours of sepsis recognition for at least four consecutive hours were enrolled. PICU patients
without evidence for sepsis, infection, or organ dysfunction for at least 48 hours were
enrolled as controls. Exclusion criteria were weight <5 kg (due to limitations of blood
collection), white blood cell count <0.5×103/μL, a known mitochondrial disorder, preexisting chronic kidney disease or liver failure, cyanotic heart disease, surgery in the
preceding 24 hours (other than for infectious source control), support with hemodialysis,
hemofiltration, and/or extracorporal membrane oxygenation, and treatment with coenzyme
Q, arginine, carnitine, or cyclosporine (due to direct mitochondrial effects).
Data Collection
Data were abstracted from the medical record onto a standardized form. Variables included
demographics, comorbid conditions, source of infection, laboratory and microbiology
results, use of vasoactive infusions, mechanical ventilation, antimicrobials, corticosteroids,
and insulin, length of stay, and vital status. Organ dysfunction was monitored for 28 days
after sepsis recognition (30). Duration of organ dysfunction was measured by the number of
organ failure-free days from study enrollment to day 28, with death corresponding to zero
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organ failure-free days (30). We compared patients with rapid recovery (within 7 days)
versus prolonged duration (greater than 7 days) of organ dysfunction based on previous
reports of the timing of maximal organ dysfunction (31) and the median time to complete
resolution of organ dysfunction in pediatric septic shock (3). Severity of illness was
determined by the Pediatric Risk of Mortality (PRISM)-III (32), Pediatric Logistic Organ
Dysfunction (PELOD) (33), and inotrope scores (34).
Blood collection
A 4.5 mL (patients ≤ 10 kg) or 6 mL (>10 kg) blood specimen was collected as soon as
possible after consent was obtained but no later than 48 hours after sepsis recognition (or
study enrollment for controls; referred to as day 1–2 specimen). For patients with sepsis, a
second blood sample was collected on study day 5–7. Assays for mitochondrial dysfunction
were performed on fresh samples immediately after blood collection.
Mitochondrial Oxygen Consumption

NIH-PA Author Manuscript

PBMCs were isolated from citrated whole blood by density gradient centrifugation. Blood
samples were diluted 1:1 using a balanced salt solution (anhydrous D-glucose 5.5mM,
CaCl2 5 mM, MgCl2 0.98 mM, KCl 5.4 mM, TRIS 145 mM, and NaCl 140 mM with pH
adjusted to 7.6) and layered on top of Ficoll-Paque PLUS (density 1.077 g/mL; Amersham
Biosciences, Piscataway, NJ). The sample was centrifuged at 400g for 40 minutes at 20–
25°C. The lymphocyte/monocyte layer at the interface was gently aspirated and centrifuged
again at 1800g for five minutes. The PBMC pellet was then resuspended in Hank’s balanced
salt solution (pH 7.40) containing 5.5 mM glucose, 1mM pyruvate, and 10 mM HEPES. Cell
counts were performed using trypan blue exclusion (Countess, Life Technologies, Grand
Island, NY) with >90% viability.
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Intact PBMCs were placed in a 2 mL chamber at a final concentration of 1–2 × 106
cells/mL. Measurements of oxygen consumption were performed at 37°C in a highresolution oxygraph (Oxygraph-2k Oroborus Instruments, Innsbruck, Austria). Oxygen flux
(in pmol O2/s/106 cells), which is directly proportional to oxygen consumption, was
recorded continuously using DatLab software 4.3 (Oroborus Instruments, Innsbruck,
Austria) as shown in Figure 1 (9). After basal oxygen consumption was recorded for 10–20
minutes, the ATP-synthase inhibitor oligomycin (1 μg/mL) was added to induce a state 4like respiration independent of mitochondrial ATP production in which oxygen consumption
was primarily due to leakage of protons across the inner mitochondrial membrane (LEAK,
abbreviated as L). In this standard protocol, it is assumed that the presence of glucose in the
polarographic assay buffer provides ample substrate to support increased cellular flux
through glycolysis and, thus, prevents critical ATP deprivation during the short-term
incubation (~10–15 minutes) with oligomycin. Maximal oxygen consumption through the
electron transport system was obtained by stepwise titration (1–2 μM) of the uncoupler
carbonyl cyanide m-chlorophenylhydrazone (CCCP) until no further increase in oxygen
consumption was detected (ETSmax, abbreviated as E). Mitochondrial respiration was then
inhibited by adding the ETS complex IV inhibitor, sodium azide, in 5–10 mM increments
until no further decrease in oxygen consumption was observed. The residual oxygen flux
following optimal azide inhibition reflects non-mitochondrial oxygen consumption and was
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subtracted from other respiration values. Oxygen consumption supporting mitochondrial
ATP synthesis (ATP-linked respiration) was calculated as basal minus LEAK respiration.
Spare respiratory capacity (SRC), a measure of mitochondrial reserve available for cells to
produce energy in response to a stress-induced increase in metabolic demand, was calculated
as ETSmax minus basal respiration. SRC indicates how close to its bionenergetic limit a cell
is operating (8). The ratio of LEAK to ETSmax (L/E or LEAK flux control ratio) is an index
for uncoupling of mitochondrial oxygen consumption from ATP synthesis (9).
Mitochondrial Membrane Potential (ΔΨm)
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ΔΨm was measured using MitoTracker Red CMXRos (MTR; Molecular Probes, Oregon).
MTR is oxidized to a fluorescent state in live cells and is sequestered within the
mitochondria in a manner directly related to ΔΨm. MitoTracker Green FM dye (MTG;
Molecular Probes, Oregon) was used to normalize ΔΨm to mitochondrial mass (35). A 50
μL sample of whole blood collected on EDTA was incubated with 5 μL of the CD45-Alexa
Fluor 647 antibody for 15 minutes in a dark room at room temperature. Separate samples
were then diluted 1:1000 in Hank’s balanced salt solution and incubated with MTR (100 nM
for 45 minutes) or MTG (100 nM for 30 minutes) at 37°C. Using an Accuri C6 flow
cytometer (BD Biosciences, San Jose, CA), the fluorescence emitted by MTR and MTG was
measured in the FL-3 channel (670 nm longpass) and FL-1 channel (530/30 nm),
respectively. The 488 nm blue laser was used for excitation and an acquisition threshold was
set to exclude Alexa Fluor 647-negative events (i.e., red blood cells and platelets). The ratio
of median fluorescence intensities of MTR and MTG was calculated using FlowJo (Treestar,
Ashland, OR).
Statistical Analysis
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Analyses were performed using STATA (Version 12.1, College Station, TX). Data are
presented as medians with interquartile ranges (IQR) for continuous variables and
frequencies with percentages for categorical variables. Comparisons between septic and
control patients were performed using the Wilcoxon rank sum test and changes in
mitochondrial dysfunction over time were analyzed using the Wilcoxon sign rank test.
Categorical variables were compared using Fisher’s exact test. The association of
mitochondrial dysfunction with organ failure-free days and severity of illness scores were
analyzed with Spearman’s rank-correlation test. Statistical significance was defined as a pvalue < 0.05.

RESULTS
Of 175 patients screened, 52 (30%) met criteria for septic shock and MODS. Fifteen (54%)
of those approached consented to study participation (Figure 2). Two patients were excluded
due to laboratory processing errors that precluded measurement of mitochondrial
dysfunction, leaving 13 septic patients for analysis. Eleven control patients were also
enrolled. Septic and control patients were similar in age (median, IQR 6.4, 2.2–12.9 versus
8.0, 3.7–15.6 years; p=0.67), sex (male 31% versus 55%; p=0.41), and race (White 38%
versus 46%, Black 31% versus 36%; p=0.77). PRISM-III scores were higher in septic (14,
7–18) than control (2, 0–2) patients (p=0.002). Table 1 shows the characteristics of the
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septic and control patients. Table 2 shows characteristics and severity of illness of the
patients at the time of blood sampling. The normal values for lactate and central venous
oxygen saturation indicate that septic patients were appropriately resuscitated prior to study
enrollment.
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As shown in Figure 3, PBMCs from septic patients on day 1–2 exhibited no differences
from controls in basal (2.53, 2.03–2.95 versus 1.81, 0.9–3.07 pmol O2/s/106 cells; p=0.62),
LEAK (0.56, 0.15–0.75 versus 0, 0–0.03 pmol O2/s/106 cells; p=0.10), or ATP-linked
respiration (2.04, 1.05–3.49 versus 2.52, 1.61, 3.13 pmol O2/s/106 cells; p=0.74). ETSmax
oxygen consumption trended lower in sepsis but this was not significant (4.30, 2.99–5.27
versus 7.50, 4.07–11.21 pmol O2/s/106 cells; p=0.10). SRC, however, was significantly
lower in PBMCs from septic patients on day 1–2 compared to controls (1.81, 0.52–2.09
versus 5.55, 2.80–7.21 pmol O2/s/106 cells; p=0.03). In addition, the ratio of LEAK to
ETSmax (L/E) was significantly higher in septic patients on day 1–2 (17%) versus controls
(<1%, p=0.047) and returned toward baseline by days 5–7 (p=0.008), suggesting partial
mitochondrial uncoupling in early sepsis (Figure 4). Although we excluded some
pharmacologic agents that strongly target mitochondria, three septic patients were treated
with the mitochondrial inhibitor valproic acid. A sensitivity analysis excluding these three
subjects paralleled the overall results with SRC trending lower in sepsis patients on day 1–2
versus controls (1.90, 0.76–2.53 versus 5.55, 2.80–7.21 pmol O2/s/106 cells; p=0.06) and
L/E trending higher in sepsis patients on day 1–2 versus controls (12% versus <1%, p=0.07).
Given the range of medications with potential effects on mitochondrial function, we list all
medications prescribed on each study day in Supplemental Table 1.
Septic PBMCs exhibited no change in basal, ATP-linked, or ETSmax oxygen consumption
over time (Figure 3). However, SRC increased as septic patients recovered organ function
(decrease in PELOD in Table 2), showing no difference from control values by day 5–7.
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Measures of PBMC mitochondrial respiration, including SRC and LEAK, did not correlate
with organ failure-free days, inotrope score, or PELOD (p>0.05 for all pair-wise
correlations). However, SRC was inversely associated with ScvO2 in septic patients on both
days 1–2 (ρ= −0.71, p=0.07) and 5–7 (ρ= −0.67, p=0.049), suggesting lower systemic
oxygen consumption in patients with diminished capacity for PBMC mitochondrial
respiration.
There were no differences in ΔΨm, normalized to mitochondrial mass, between controls and
septic patients on day 1–2 or day 5–7 (Figure 5A). Within the septic group, there was a weak
linear association between ΔΨm and organ failure-free days (ρ=0.56, p=0.06). Septic
patients with recovery of organ function by day seven exhibited a higher ΔΨm on day 1–2
(MTR/MTG ratio 0.62, IQR0.47, 0.82) compared to septic patients with organ dysfunction
for more than seven days (0.32, IQR 0.14–0.35; p=0.04) and controls (0.19, IQR 0.15–0.37;
p=0.02; Figure 5B).
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Our data is the first to demonstrate that mitochondrial dysfunction is evident in PBMCs
from critically ill children with septic shock and MODS. We found that mitochondrial
bioenergetic reserve, indicated by spare respiratory capacity, was significantly diminished in
PBMCs early in pediatric sepsis with a possible increase in mitochondrial uncoupling.
Although mitochondrial respiration was not associated with the severity or duration of organ
dysfunction in this small sample, septic patients with recovery from organ dysfunction by
day seven exhibited a higher PBMC ΔΨm relative to mitochondrial mass compared to septic
patients with prolonged organ dysfunction.
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Decreased SRC indicates mitochondrial dysfunction that may not be apparent under basal
conditions but becomes manifest as stress and ATP demand increases (8). SRC is a critical
determinant of cell survival and function in a variety of cell types (10), including immune
cells (11). If SRC is not sufficient to meet a stress-induced increase in metabolic demand (as
is present in sepsis), cells may experience an energetic exhaustion that can lead to organ
dysfunction. In the case of PBMCs, this may present clinically as immune dysregulation or
suppression. Prior studies have shown that reduced mitochondrial respiration in PBMCs is
associated with immunosuppression in adult sepsis (18) and in hemorrhagic shock (26). The
combined observations in this study that basal oxygen consumption was maintained while
SRC was diminished suggests that PBMCs are respiring near maximal levels during early
sepsis in order to maintain ATP-linked oxygen consumption and other mitochondrial
functions. Although a metabolic transition from oxidative phosphorylation to glycolysis
upon PBMC activation (particularly in lymphocytes) could help to preserve overall cellular
ATP production, oxidative phosphorylation remains critical to PBMC survival (23, 24) and
these immune cells appear to be dangerously close to the point of mitochondrial bioenergetic
failure early in pediatric sepsis.
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Our pediatric data agree with several prior studies in adult sepsis that have reported
decreased mitochondrial oxygen consumption in PBMCs from septic adults (18–20). For
example, Belikova et al. found that maximal oxygen consumption in the presence of
uncoupler was decreased (though SRC was not explicitly calculated) and the fraction of
LEAK respiration was increased compared to healthy controls (18). In contrast to these
findings, however, Sjovall et al. demonstrated a progressive increase in basal and maximal
respiration in adult PBMCs on day 1–2 through day 6–7 of sepsis compared to healthy
controls (21). These contradictory findings may stem from methodological variability
between studies. For example, we isolated PBMCs in respiration buffer solution while
Sjovall et al. resuspended cells in plasma (21). If intracellular mitochondrial substrates (e.g.,
fatty acids, NADPH) are limited in sepsis, the lack of available plasma-derived substrates
could account for the decrease in maximal oxygen consumption we observed in septic
PBMCs compared to the increase observed in the study by Sjovall et al. Alternatively, prior
studies have shown that septic plasma increases mitochondrial uncoupling, which should
decrease SRC (36, 37). Because this effect appears reversible (18), resuspension of PBMCs
in a standard buffer provides a more direct measure of intrinsic PBMC mitochondrial
function as well as reduces variability in plasma factors between patients (e.g, different
medications). However, as PBMCs function in their plasma environment, it is not clear if
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resuspension in plasma more accurately approximates in vivo PBMC mitochondrial
function.
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We also found that the proportion of maximal mitochondrial respiration attributable to
LEAK increased from <1% in controls to 17% during early sepsis. An increase in LEAK
respiration suggests that mitochondrial oxygen consumption has become uncoupled from
ATP synthesis, rendering oxidative phosphorylation less efficient. However, less wellcoupled mitochondrial also produce less reactive oxygen species and thus could be a
protective mechanism to limit oxidative damage at the expense of a small loss of energy (8).
While this finding is suggestive of an increase in mitochondrial uncoupling, it should be
noted that the L/E ratio may also increase in normally coupled mitochondria if the ETSmax is
diminished as was the trend in our study. Furthermore, prior studies using PBMCs from
healthy animals and human adults have reported L/E ratios ranging 1–10% (18, 21, 26, 38).
The L/E ratio of ~1% observed in our PICU controls was at the lower end of this range,
which could reflect either tightly coupled PBMC mitochondria in non-septic PICU patients
or the challenge of accurately measuring LEAK in cases where these values approach
residual oxygen consumption.
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We were surprised to find no difference in ΔΨm between septic and control patients since
reduced ΔΨm has been reported in PBMCs from adult patients with sepsis (17, 19). Several
possible explanations may account these divergent findings. First, as the one nonsurvivor
had the lowest MTR/MTG ratio in our cohort, differences in ΔΨm may have been more
apparent if mortality was higher. Second, it has been proposed that MTG itself may be
affected by changes in ΔΨm leading to inaccurate measures of ΔΨm using the MTR/MTG
ratio (39). While we did not see large changes in MTG with purposeful dissipation of ΔΨm
in preliminary work (data not shown), we cannot rule out this possibility. Third, relying on
the median MTR/MTG value may fail to discern important changes in ΔΨm in subgroups of
septic patients. In support of this explanation, we found that patients with full recovery of
organ dysfunction within seven days exhibited the highest MTR/MTG ratio. A rise in
MTR/MTG may reflect either an increase in ΔΨm or a decrease in mitochondrial mass.
Mitochondrial hyperpolarizaton (increased ΔΨm) protects against formation of the
mitochondrial transition pore and thus reduces apoptosis. Insufficient mitophagy of damaged
mitochondria has been shown to contribute to organ injury in critical illness (40). Thus,
either mitochondrial hyperpolarization (higher MTR) or reduced mitochondrial mass (lower
MTG) could potentially underlie the rapid recovery in the subset of patients with highest
MTR/MTG ratio.
We did not find an association between PBMC mitochondrial respiration and severity or
duration of organ failure in our pediatric patients. Two prior studies using PBMCs in adult
sepsis reported an association between reduced mitochondrial respiration and degree of
organ injury (19, 20) while a third did not find an association with mortality (21). Given
evidence for mitochondrial injury in pre-clinical and adult studies, it is unlikely that vital
organ mitochondria remain unaffected in pediatric sepsis. Rather, PBMCs may be an
inadequate biomarker of mitochondrial dysfunction in other organs (22). We previously
reported strong correlation between mitochondrial dysfunction measured in PBMCs and
heart, liver, and kidney cells early in a hemorrhagic shock model, but noted substantial
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variability in mitochondrial respiration across organs after resuscitation (27). Moreover, use
of a relatively crude mix of PBMCs provides only a weighted average of bioenergetic
activity across diverse cell types with known differences in both glycolytic and
mitochondrial function. More research is needed to determine if specific leukocyte subsets
could provide a stronger clinical biomarker for mitochondrial dysfunction in other organ
systems.
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There are several limitations to this study. First, minor but significant changes in
mitochondrial function would not have been detected in this small study. Our selection of
PICU controls versus healthy children may also have biased results toward the null if PBMC
mitochondrial function is similarly inhibited by non-septic illness. Second, although we
excluded some known pharmacological agents that target mitochondria, given the small
sample size, we were not able to control for other potential medication effects on
mitochondrial function. However, a sensitivity analysis excluding patients receiving valproic
acid yielded similar results to the overall analysis. Second, we normalized measures of
oxygen consumption to cell number but not mitochondrial content. A recent study
demonstrated that changes in mitochondrial content may be an important cause of altered
cellular respiration (21). Third, because we were interested in the occurrence of
mitochondrial dysfunction in patients with persistent MODS despite adequate resuscitation,
we did not determine if peak mitochondrial injury may be antecedent to or concurrent with
shock onset. In addition, although we excluded patients with prolonged hypotension in order
to limit the impact of inadequate resuscitation on mitochondrial measurements, this may
have also excluded the most severely ill patients. Finally, because we considered PBMCs all
together, we do not have information about differences in mitochondrial dysfunction within
subpopulations of immune cells (e.g., monocytes, T- and B-lymphocytes). Further insight
into the complete bioenergetic profile of distinct leuckocyte subests may also be elucidated
by studying these cells under both resting and immunostimulated conditions, similar to
provocative assessments of immune function (5).

CONCLUSIONS
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Mitochondrial dysfunction, indicated by a decreased spare respiratory capacity and
increased uncoupling, occurs in PBMCs from critically ill children with septic shock and
MODS. PBMCs may be operating at or near their maximum oxidative respiratory capacity
early in pediatric septic shock, leaving these cells vulnerable to stress, bioenergetic
exhaustion, and dysfunction. Changes in PBMC mitochondrial membrane potential (ΔΨm)
relative to mitochondrial mass, but not respiration, were associated with duration of organ
failure. Future studies using PBMCs could provide insight into the linkages between
mitochondrial dysfunction, immune dysregulation, and organ injury in pediatric sepsis.
Supplemental Table 1: Medications prescribed to patients at time of blood sampling
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Figure 1.

Representative tracing of oxygen consumption measured in intact PBMCs. The solid black
line shows the amount of oxygen present in the chamber over time. The dashed black line
shows the rate of oxygen consumption (oxygen flux). After measuring basal oxygen
consumption, the ATP-synthase inhibitor oligomycin is added to obtain LEAK. Then, to
measure maximal oxygen consumption, the uncoupler carbonyl cyanide mchlorophenylhydrazone (CCCP) is repeatedly added until no further increase in oxygen
consumption is detected. Residual, non-mitochondrial respiration is obtained by adding the
ETS complex IV inhibitor, sodium azide, which is then subtracted from the other
measurements. Finally, ATP-linked oxygen consumption is calculated as basal minus LEAK
and spare respiratory capacity (SRC, double-headed arrow) is calculated as maximal minus
basal oxygen consumption.
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Figure 2.

Patient screening and study enrollment.
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Figure 3.

Mitochondrial oxygen consumption was measured in PBMCs. Septic shock reduces spare
respiratory capacity (SRC) but not basal, LEAK, or ATP-linked oxygen consumption in
PBMCs on day 1–2. By day 5–7, SRC normalized but ATP-linked oxygen consumption was
decreased below control values. Data are presented in box plot analysis with the central line
indicating the median and the white (control) and gray (sepsis) boxes indicating the
interquartile range. *p=0.03, **p=0.02
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Figure 4.

LEAK flux control ratio. The ratio of LEAK to ETSmax respiration (L/E) is an index for
uncoupling of mitochondrial oxygen consumption from ATP synthesis. Each bar represents
the median maximal oxygen consumption through the ETS (ETSmax) obtained by stepwise
titration of uncoupler. The black portion of each bar is the L/E ratio, or proportion of
maximal respiration not inhibited by oligomycin (called LEAK respiration). The L/E ratio
was highest in septic patients on day 1–2, suggesting partial mitochondrial uncoupling early
in pediatric sepsis.
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Figure 5.
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Assessment of mitochondrial membrane potential (ΔΨm) in PBMCs. MitoTracker Red
(MTR) indicates ΔΨm and MitoTracker Green (MTG) indicates mitochondrial mass. A,
ΔΨm, normalized to mitochondrial mass, was not different between controls and septic
patients on day 1–2 or day 5–7. Data are presented in box plot analysis with the central line
indicating the median and the white (control) and gray (sepsis) boxes indicating the
interquartile range. B, In septic patients, MTR/MTG on day 1–2 weakly correlated with
organ failure-free days (dashed line, ρ=0.56, p=0.06). Control patients cluster at 28 organ
failure-free days because none had organ dysfunction during the study period. MTR/MTG
was higher in septic patients with a short duration of organ failure ≤7 days (i.e., more organ
failure-free days, shaded region) compared to septic patients with organ failure duration >7
days (p=0.04) and controls (p=0.02).
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Patient characteristics
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Micro-organism

3

5

0

2

12

3

0

0

0

0

6

2

30

18

31

9

14

7

11

6

15

14

0

22

PRISM-IIIb
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Respiratory syncytial virus

Human metapneumovirus

e

d

A, alive; D, deceased

c

PRISM-III score on day of PICU admission

b

Number of organ failures at time of informed consent/assent
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Clinical features of patients at time of blood sampling
Controls

Sepsis (Day 1–2)

Sepsis (Day 5–7)

PELOD score

0 (0–0)

11 (10–11)

1 (0–10)

Inotrope score

0 (0–0)

9 (5–13)

7 (3–11)

9.4 (7.9–10.7)b

9.8 (8.6–11.5)

9.8 (8.1–11.4)

PBMCs (per μL)a

1905 (1208–2765)b

1615 (1372–2700)

2958 (2187–3990)

Lymphocytes (per μL)

1270 (900–2370)b

1131 (801–1914)

2156 (1768–3306)

434 (395–635)b

448 (285–696)

696 (486–1048)

Lactate (mmol/L)

n/a

0.9 (0.7–1.3)

0.9 (0.9–1.6)

ScvO2 (%)

n/a

75 (71–83)

76 (70–80)

Corticosteroids, n (%)

2 (18)

5 (38)

4 (40)

Insulin, n (%)

1 (9)

0

0

0

0

0

WBC (thous/μL)

Monocytes (per μL)

Aminoglycoside, n(%)
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Values are median (interquartile range), unless otherwise noted
PELOD; Pediatric Logistic Organ Dysfunction; WBC, white blood cell count; PBMCs; peripheral blood mononuclear cells; ScvO2; central venous
oxygen saturation; n/a, data not available
a

Absolute number of lymphocytes and monocytes on complete blood count

b

Complete blood count data available from only 9 of the 11 control patients

NIH-PA Author Manuscript
Pediatr Crit Care Med. Author manuscript; available in PMC 2016 January 01.

